pharmaceutical-investing Scilex Announces Pricing and Availability of ZTlido for the Commercial Launch of its First Product in October of 2018
pharmaceutical-investing Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing
Eagle Energy Metals Corp. and Spring Valley Acquisition Corp. II Announce Effectiveness of Registration Statement and Record and Meeting Dates for Extraordinary General Meeting of Shareholders to Approve Proposed Business Combination
